Clin2
NCT07059208Possibly a fitNot yet recruiting

Comparing two heart procedures for atrial fibrillation in older patients

Atrial Fibrillation (AF)

Part of Heart & circulation clinical trials.

This trial compares two ways to control atrial fibrillation (an irregular heartbeat) in older patients: destroying a small area of the heart's electrical pathway and implanting a pacemaker, versus a procedure to isolate the veins that trigger the irregular beats. The goal is to see which approach gives you better results and fits your preferences.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
172 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are at least 65 (for persistent AF) or at least 75 (for paroxysmal AF) years old.
  • You have tried at least one heart rate or rhythm medicine that didn't help or that you couldn't tolerate.
  • You have a resting heart rate above 70 bpm on a rate-control medicine (or above 90 bpm without one), as seen on an ECG.
  • You have not had a prior catheter ablation for AF, left atrial flutter, or AV node ablation.
  • Your body mass index (BMI) is 40 or lower.
  • You are able to undergo the procedures (pulmonary vein isolation or pacemaker implantation) based on your overall health.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06745167Not yet recruiting
Comparing two procedures to treat persistent atrial fibrillation

This trial compares two minimally invasive heart procedures for persistent atrial fibrillation (a type of irregular heartbeat). The aim is to see which one is safer and more effective at restoring a normal heart rhythm.

Shanghai, Shanghai Municipality
NCT07238452Not yet recruiting· Phase 3
Comparing treatment options for atrial fibrillation in people with heart failure

This study compares two different treatment strategies for atrial fibrillation (an irregular heartbeat) in people who also have heart failure. One strategy uses medications only, while the other includes a procedure to restore normal heart rhythm. The goal is to find the best way to improve symptoms and outcomes.

NCT06929897Enrolling by invitation
Comparing Two Ablation Methods for Persistent Atrial Fibrillation

This study compares two types of ablation (a procedure that uses energy to fix irregular heartbeats) for people with persistent atrial fibrillation. It tests whether adding extra treatment to the back of the heart's left upper chamber helps improve outcomes compared to standard treatment alone.

Seoul
NCT07783919Not yet recruiting
Comparing two pulsed field ablation methods for atrial fibrillation

This trial compares two different ways of delivering pulsed field ablation—a newer, targeted energy that zaps abnormal heart tissue—for people with atrial fibrillation. It aims to see if a single broader application works as well as a more focused, two-step approach, and it may help you feel better if you have symptoms from this irregular heartbeat.

Herne, North Rhine-Westphalia
NCT07424690Recruiting
Comparing ablation with medication care for older adults with atrial fibrillation

This study compares two approaches for older adults with atrial fibrillation: a procedure called catheter ablation (which uses heat or cold to fix the heart's rhythm) versus conservative care (medications and lifestyle changes). The goal is to see which approach is better for improving quality of life and reducing symptoms in people aged 78 and above.

Linköping
NCT06866704Not yet recruiting
Comparing two ablation methods for persistent atrial fibrillation

This study compares two procedures to treat persistent atrial fibrillation (an irregular heartbeat that lasts more than a week). It looks at whether a newer method (pulsed-field ablation) works better than the standard method (radiofrequency ablation), both combined with a chemical injection to improve treatment success.

Hear when a new Atrial Fibrillation (AF) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.